IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases
Comparteix aquest contingut
Related professionals
Dr. Rafael
Touriño García
Touriño García
Dr. Rafael
Touriño García
Touriño García
Dr. Xabier
Michelena Vegas
Michelena Vegas
Sr. Salvador
Campos Badia
Campos Badia
Dra. Mª Alba
Erra Duran
Erra Duran
Dra. Mª Alba
Erra Duran
Erra Duran
Dra. Josefina
Cortés Hernández
Cortés Hernández
Dra. Josefina
Cortés Hernández
Cortés Hernández
Systemic Diseases
Dra. Mireia
Lopez Corbeto
Lopez Corbeto
Dra. Mireia
Lopez Corbeto
Lopez Corbeto
Dra. Helena
Borrell Paños
Borrell Paños
Dra. Helena
Borrell Paños
Borrell Paños
Dr. Ramon
Sanmartín Sentañes
Sanmartín Sentañes
Dr. Ramon
Sanmartín Sentañes
Sanmartín Sentañes
Dra. Mayte
Serrat Lopez
Serrat Lopez
Dra. Mayte
Serrat Lopez
Serrat Lopez
Dr. Gustavo
Añez Sturchio
Añez Sturchio
Dr. Gustavo
Añez Sturchio
Añez Sturchio
Researcher
Immunomediated Diseases and Innovative Therapies, Systemic Diseases
Dra. Andrea
Pluma Sanjurjo
Pluma Sanjurjo
Dra. Andrea
Pluma Sanjurjo
Pluma Sanjurjo
Sra. Marta
Muste Diaz
Muste Diaz
Dra. Maria
López Lasanta
López Lasanta
Dra. Maria
López Lasanta
López Lasanta
News and events